Projects per year
Personal profile
Education
- 2012 PhD, Institute of Clinical Medicine, National Cheng Kung University
Experience
- 2005.7~Present Attending Physician, Department of Internal Medicine, NCKUH
- 2013.2~2015.8 Clinical Assistant professorr/Department of Internal Medicine, NCKU
- 2015.8~present Assistant Professor/Institute of Clinical Medicine, NCKU
Research Interests
- Clinical Oncology
- Anti-Cancer Pharmacology
- DNA Repair and Anti-Oxidant Stress in Oncology
- Cellular Resistance to Anti-Cancer Therapy and its Clinical Application
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Wen-Pin Su is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 15 Finished
-
-
以多重研究法解開組織缺氧-纖維化循環在胰臟癌之病理機制及發展新穎治療策略-開創抗Hypoxia之胰臟癌新治療—藉由pH-sensitive攜帶Sitravatinib的奈米粒子，以提升PD-1 抗體之療效( II )
21-08-01 → 22-07-31
Project: Research project
-
以多重研究法解開組織缺氧-纖維化循環在胰臟癌之病理機制及發展新穎治療策略-開創抗Hypoxia之胰臟癌新治療—藉由pH-sensitive攜帶Sitravatinib的奈米粒子，以提升PD-1 抗體之療效( I )
20-08-01 → 21-07-31
Project: Research project
-
-
PD-L1不只是Biomarker！探討肺癌細胞本身的PD-L1促進轉移的機轉，及其與TIP60-mediated 癌症EMT的相關性
19-08-01 → 20-07-31
Project: Research project
-
BMP2 promotes lung adenocarcinoma metastasis through BMP receptor 2-mediated SMAD1/5 activation
Wu, C. K., Wei, M. T., Wu, H. C., Wu, C. L., Wu, C. J., Liaw, H. & Su, W-P., 2022 Dec, In: Scientific reports. 12, 1, 16310.Research output: Contribution to journal › Article › peer-review
Open Access -
Chemical Structure and Shape Enhance MR Imaging-Guided X-ray Therapy Following Marginative Delivery
Wang, L. C., Chang, L. C., Su, G. L., Chang, P. Y., Hsu, H. F., Lee, C. L., Li, J. R., Liao, M. C., Thangudu, S., Treekoon, J., Yu, C. C., Sheu, H. S., Tu, T. Y., Su, W. P., Su, C. H. & Yeh, C. S., 2022 Mar 23, In: ACS Applied Materials and Interfaces. 14, 11, p. 13056-13069 14 p.Research output: Contribution to journal › Article › peer-review
3 Citations (Scopus) -
Efficacy and safety of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma: long-term follow-up of a phase 2 study
BLC2001 Study Group, 2022 Feb, In: The Lancet Oncology. 23, 2, p. 248-258 11 p.Research output: Contribution to journal › Article › peer-review
19 Citations (Scopus) -
Immunotherapy for Cancer: Strategies of Immunomodulation Therapy in Combination with Conventional Approaches
Gupta, T., Murtaza, M., Ghosh, M., Su, W. P., Pandey, N. K. & Goutam, U., 2022, In: Eurasian Journal of Medicine and Oncology. 6, 1, p. 1-11 11 p.Research output: Contribution to journal › Review article › peer-review
Open Access -
Polyaniline-Based Glyco-Condensation on Au Nanoparticles Enhances Immunotherapy in Lung Cancer
Su, W. P., Chang, L. C., Song, W. H., Yang, L. X., Wang, L. C., Chia, Z. C., Chin, Y. C., Shan, Y. S., Huang, C. C. & Yeh, C. S., 2022 Jun 1, In: ACS Applied Materials and Interfaces. 14, 21, p. 24144-24159 16 p.Research output: Contribution to journal › Article › peer-review
1 Citation (Scopus)